QHSLab, Inc.
Close on Oct 19, 2026
- Market cap
- $7.38M
- P/E (TTM)
- –
- Dividend yield
- –
About QHSLab
Surgical & Medical Instruments & Apparatus, SIC 3841
QHSLab, Inc. is a digital health company that enables independent, physician-led primary care practices to detect, document, and manage behavioral health conditions. Its workflow-integrated digital platform facilitates population-based screening, adaptive clinical risk assessments, automated documentation within electronic health records, and longitudinal non-face-to-face care management. Alongside its digital software, the company offers AllergiEnd, an allergy diagnostics and treatment line featuring disposable skin test applicators and customized immunotherapy support to evaluate and treat allergic conditions directly within clinical practices. Its primary target clientele consists of independent medical practices with one to ten healthcare providers.
The company conducts its operations from its principal executive offices located in West Palm Beach, Florida. Its workforce includes twelve full-time employees dedicated to direct sales and operational functions, supplemented by independent contractors and professional consultants. The company focuses its commercial offerings on primary care practices across the United States.
Summary of the business section of QHSLab's latest annual report, written by StockData.
Company profile
Company
- Legal name
- QHSLab, Inc.
- Headquarters
- West Palm Beach, FL
- Address
- 901 Northpoint Parkway, Suite 302 33407
- Phone
- (929) 379-6503
- Website
- qhslab.com
- Employees
- 12, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- Astra Audit & Advisory LLC, Tampa, Florida
Stock & identifiers
- Ticker
- USAQ
- Exchange
- OTC
- IPO date
- May 22, 2013
- Shares outstanding
- 15M, Aug 12, 2026
- Public float
- $1.56M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- SEC CIK
- 856984
- CUSIP
- 90350R107
- ISIN
- US90350R1077
- LEI
- 549300D1JZOF6KBGCN47
- EIN
- 11-2655906
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Troy James Grogan | President and CEO, Director | 3,892,046 |
Employees
Headcount reported in annual reports
“As of March 30, 2026, we had twelve employees devoting full-time services to the Company, all of whom were engaged in direct sales and operations.”
Corporate history
Events identified from SEC filings